STOP Med-HD: Strategic optimization of prescription medication use in patients on hemodialysis

Study Lead

Marisa Battistella

Toronto General Hospital, University Health Network

Overview

Patients on hemodialysis (HD) take 12 medications per day on average. Sometimes, certain medications can be gradually reduced or removed to decrease the number of pills a patient needs to take and possibly the negative effects of taking so many medications (for example: side effects related to taking the drug, drug interactions). This is called “deprescribing”. Our research team developed and is implementing deprescribing tools in HD units across Canada to help medical teams in HD units identify and deprescribe medications that certain patients might not need.

We are looking to interview patient partners (who are 18+ and in Canada) with chronic kidney disease to learn about their experience with chronic kidney disease, taking multiple medications, and/or deprescribing. The interview will take place over video call (e.g. Zoom) and will take approximately 10-15 minutes. Our research team will create a short video and include recorded clips from the interviews with patients. We will share the video with patients, clinicians, and research partners.

Estimated time commitment: 40 minutes – 20 minutes max for interview; 20 minutes max to provide feedback on video

Eligibility

Patients 18+ with chronic kidney disease and/or on hemodialysis.

Type of Participation

Interview

Diagnosis

Chronic Kidney Disease

Treatment

Hemodialysis

Location

All provinces and territories

Related studies

  • Mind the Gap

    Overview: Identifying and implementing individualized, accessible, and culturally sensitive solutions to address mental health care in individuals receiving hemodialysis

    Study type: Patient Partnership, Survey

    February 2, 2024

  • Home First: A pragmatic provincial clinical demonstration project in advanced Chronic Kidney Disease

    Overview: The goal of this program is to offer all patients with advanced CKD in the Manitoba Renal Program enhanced dialysis education and support from a patient navigator.

    Study type: Patient Partnership

    January 25, 2024

  • Multispectral Colour Sensing Point-of-Care Testing Device for CKD Monitoring

    Overview: Developing a point-of-care device that uses advanced colour sensors to measure creatinine levels in the urine to improve Chronic Kidney Disease monitoring.

    Study type: Interview

    January 24, 2024